NEURELIS, INC.

Profile

Company Names

NEURELIS, INC.

Addresses

3430 CARMEL MOUNTAIN ROAD, SUITE 300, SAN DIEGO, CA 92121

11682 EL CAMINO REAL, SUITE 255, SAN DIEGO, CA 92130

12340 EL CAMINO REAL, SUITE 425, SAN DIEGO, CA 92130

1042-B N. EL CAMINO REAL, SUITE 430, ENCINITAS, CA 92024

Phone Numbers

858-531-5859
(858) 531-5859
(858) 756-2480

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$221,841,880.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2021-02-26 
$114,759,923.00 
$120,021,902.00 
$5,261,979.00 
Equity 
7
2019-10-17 
$42,098,007.00 
$42,098,007.00 
$0.00 
Equity 
6
2018-11-08 
$40,500,000.00 
$40,500,000.00 
$0.00 
Equity 
5
2018-08-07 
$5,200,000.00 
$15,000,000.00 
$9,800,000.00 
Debt 
4
2016-12-29 
$15,000,000.00 
$20,000,000.00 
$5,000,000.00 
Equity 
3
2015-07-02 
$1,500,000.00 
$10,000,000.00 
$8,500,000.00 
Equity 
2
2011-09-19 
$1,083,950.00 
$1,083,950.00 
$0.00 
Debt 
1
2010-01-19 
$1,700,000.00 
$2,400,000.00 
$700,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PRIYANKA 
 
BELAWAT 
DIRECTOR
NEURELIS, INC.   |  ITEOS THERAPEUTICS, INC.
STEPHEN 
 
CARTT 
DIRECTOR
NEURELIS, INC.
CRAIG 
C. 
CHAMBLISS 
EXECUTIVE OFFICER, DIRECTOR
NEURELIS, INC.
CAM 
 
GARNER 
DIRECTOR
ZOGENIX INC   |  NANOTHERA CORP   |  SG PHARMACEUTICALS, INC.   |  NEURELIS, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  ONCTERNAL THERAPEUTICS, INC.
CAM 
L. 
GARNER 
DIRECTOR
ZOGENIX INC   |  MERITAGE PHARMA INC   |  ELEVATION PHARMACEUTICALS INC   |  NEURELIS, INC.   |  EVOKE PHARMA INC   |  KALYRA PHARMACEUTICALS, INC.   |  ORPRO THERAPEUTICS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  ONCTERNAL THERAPEUTICS, INC.
DAVID 
A. 
GONYER 
DIRECTOR
EVOKE PHARMA INC   |  NEURELIS, INC.
DAVID 
F. 
HALE 
DIRECTOR, EXECUTIVE OFFICER
SKINMEDICA INC   |  SOMAXON PHARMACEUTICALS, INC.   |  NEURELIS, INC.   |  RIDGE DIAGNOSTICS, INC.   |  CONATUS PHARMACEUTICALS INC   |  AGILITY CLINICAL, INC.   |  COLORESCIENCE INC   |  TOKALAS, INC.   |  RECROS MEDICA, INC.   |  IDUN PHARMACEUTICALS INC   |  MDREJUVENA, INC.   |  DERMATA THERAPEUTICS, LLC   |  ONCTERNAL THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  CLARIFY MEDICAL, INC.   |  ONCTERNAL THERAPEUTICS, INC.
WILLIAM 
R. 
LARUE 
DIRECTOR
NEURELIS, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  ALASTIN SKINCARE, INC.   |  ONCTERNAL THERAPEUTICS, INC.
KEVIN 
 
LI 
DIRECTOR
NEURELIS, INC.   |  QPEX BIOPHARMA, INC.   |  IGENOMX INTERNATIONAL GENOMICS CORP   |  JUMPCODE GENOMICS, INC.   |  MULTIVERSE, INC.   |  WUGEN, INC.
HUAIZHENG 
 
PENG 
DIRECTOR
HELIUS MEDICAL TECHNOLOGIES, INC.   |  NEURELIS, INC.   |  MIDATECH PHARMA PLC
GEORGE 
 
STUART 
EXECUTIVE OFFICER
NEURELIS, INC.
YONG 
 
ZHANG 
DIRECTOR
DREAMFUND HOLDINGS, INC.   |  NEURELIS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-26 
2020-10-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-17 
2020-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-17 
2018-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-08 
2018-08-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-07 
2017-12-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-29 
2017-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-29 
2015-07-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-02 
2011-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-09-19 
2010-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-01-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AQUILO PARTNERS, L.P.
114909